Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines

Clinical trial NCT00254917 · COMPLETED

Trial details

NCT number: NCT00254917
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diphtheria Tetanus Polio Pertussis Haemophilus Influenzae Type B

Start date: 2003-10-01
Primary completion: 2006-02-01
Enrollment: 387

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.